High doses of favipiravir in two men survivors of Ebola virus disease carrying Ebola virus in semen in Guinea

This publication has 19 references indexed in Scilit:

• Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus
  Antiviral Research, 2018
• Dynamics of Ebola RNA Persistence in Semen: A Report From the Postebogui Cohort in Guinea
  Clinical Infectious Diseases, 2017
• Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted
  PLOS Neglected Tropical Diseases, 2017
• Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study
  The Lancet Global Health, 2017
• Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials
  Clinical Pharmacokinetics, 2016
• Molecular Evidence of Sexual Transmission of Ebola Virus
  New England Journal of Medicine, 2015
• Lack of effect of favipiravir, a novel antiviral agent, on QT interval in healthy Japanese adults
  Int. Journal of Clinical Pharmacology and Therapeutics, 2015
• Evaluation of Antiviral Efficacy of Ribavirin, Arbidol, and T-705 (Favipiravir) in a Mouse Model for Crimean-Congo Hemorrhagic Fever
  PLOS Neglected Tropical Diseases, 2014
• Post-exposure efficacy of Oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model
  Antiviral Research, 2014
• Spermatogene Übertragung des „Virus Marburg“
  Journal of Molecular Medicine, 1968